Puyue, a subsidiary of Shanghai Kindly Medical, has received Shanghai Medical Products Administration (SMPA) approval of Digital Rigid Ureteroscope.

Indications for Use Statement

Digital Rigid Ureteroscope is used in conjunction with INT’s Electronic Ureteroscope Image Processor (PY-IPE) to enter the human body via the urethra and perform endoscopic imaging of the ureter and renal pelvis. It cannot be used with high frequency accessories.

About Digital Rigid Ureteroscope

Certificate No.: 20242060102

Registrant:  Shanghai INT Medical Instrument Co., Ltd.

Address:   Floor 2, Building 1. No.925, Jinyuan Yi Road, Jiading District, Shanghai, 201803.

Approval Date: 04/05/2024

Expire Date: 04/04/2029

About Puyue Medical

Founded in March 2021, Shanghai Puyue Medical Instrument Co., Ltd. is an innovative provider of comprehensive surgical solutions in urology field. Puyue mainly engages in the research, development, production, and sales of products and equipment for urological surgeries. The core values of Puyue are human-centeredness, equality and respect, collaborative innovation, harmonious coexistence, and returning to simplicity. Puyue is committed to building a community of medical, industrial, and trade enterprises, dedicated to safeguarding human health, safety, and happiness.

About Shanghai INT Medical

Shanghai INT Medical Instruments Co., Ltd. was established in 2006, a listed company on main board of Hong Kong Exchange (KDL Medical; HK1501).

Shanghai INT Medical owns 14 subsidiaries with over 1,600 employees. The headquarter is located in Jiading, Shanghai, manufacturing cardiovascular, peripheral and neuro intervention products approved by CE and FDA (510K), with a complete industrial chain of independent mold processing, product research and development, equipment development, sterilization, etc..

Shanghai INT Medical will keep to uphold the concept of “Innovation serves health, high-quality achieves excellence”, contributing to development of global medical equipment industry and providing patients with more high-quality and diverse treatment options.